| EPA0002 | Preexisting and postbaseline resistance analyses in pooled pediatric studies of emtricitabine/tenofovir alafenamide (F/TAF)-based antiretroviral therapy (ART) | E-poster | HIV virology |
| EPA0003 | Wide diversity in SIV production occurs at the single cell level | E-poster | HIV virology |
| EPA0004 | Characterization of Brazilian HIV-1 near full-length proviral genomes from people living with HIV under successful first-line antiretroviral therapy | E-poster | HIV virology |
| EPA0005 | HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells | E-poster | HIV virology |
| EPA0006 | Rilpivirine-associated resistance mutations among virologically suppressed people living with HIV-1 in Botswana: implications for cabotegravir-rilpivirine use | E-poster | HIV virology |
| EPA0007 | Identification of a new HIV-1 BF1 intersubtype recombinant form circulating in Turkey, that has generated a secondary recombinant form with CRF56_cpx transmitted in Spain | E-poster | HIV virology |
| EPA0008 | Viral reservoir diversity in circulating PMBC and T cell subsets under suppressive ART | E-poster | HIV virology |
| EPA0009 | Development of an efficient method based on Nanopore technology for sequencing of HIV-1 near full-length genomes from plasma | E-poster | HIV virology |
| LBEPA01 | Large decrease in the proportion of newly diagnosed HIV-1 infections grouping in large clusters in Spain | E-poster | HIV virology |
| LBEPA08 | HIV-infected macrophages can be made susceptible to antibody dependent cellular cytotoxicity by small molecule CD4 mimetics | E-poster | HIV virology |